2017-2025 World Neuromyelitis Optica Drug Market Research Report (by Product Type, End-User/Application and Regions/Countries)
SUMMARY
Neuromyelitis optica (NMO) is an uncommon disease syndrome of the central nervous system (CNS) that affects the optic nerves and spinal cord. Individuals with NMO develop optic neuritis, which causes pain in the eye and vision loss, and transverse myelitis, which causes weakness, numbness, and sometimes paralysis of the arms and legs, along with sensory disturbances and loss of bladder and bowel control. NMO leads to loss of myelin, which is a fatty substance that surrounds nerve fibers and helps nerve signals, move from cell to cell. The syndrome can also damage nerve fibers and leave areas of broken-down tissue. In the disease process of NMO, for reasons that aren't yet clear, immune system cells and antibodies attack and destroy myelin cells in the optic nerves and the spinal cord.Neuromyelitis optica drug is drug used in the treatment of neuromyelitis optica, in this report we focused on Glucocorticoids such as Methylprednisolone and Immunoglobulin such as IVIg.
This report includes market status and forecast of global and major regions, with introduction of vendors, regions, product types and end industries; and this report counts product types and end industries in global and major regions.
The report includes as follows:
The report provides current data, historical overview and future forecast.
The report includes an in-depth analysis of the Global market for Neuromyelitis Optica Drug , covering Global total and major region markets.
The data of 2017-2025 are included. All-inclusive market are given through data on sales, consumption, and prices (Global total and by major regions).
The report provides introduction of leading Global manufacturers.
Neuromyelitis Optica Drug market prospects to 2025 are included (in sales, consumption and price).
Market Segment as follows:
By Region / Countries
Neuromyelitis optica (NMO) is an uncommon disease syndrome of the central nervous system (CNS) that affects the optic nerves and spinal cord. Individuals with NMO develop optic neuritis, which causes pain in the eye and vision loss, and transverse myelitis, which causes weakness, numbness, and sometimes paralysis of the arms and legs, along with sensory disturbances and loss of bladder and bowel control. NMO leads to loss of myelin, which is a fatty substance that surrounds nerve fibers and helps nerve signals, move from cell to cell. The syndrome can also damage nerve fibers and leave areas of broken-down tissue. In the disease process of NMO, for reasons that aren't yet clear, immune system cells and antibodies attack and destroy myelin cells in the optic nerves and the spinal cord.Neuromyelitis optica drug is drug used in the treatment of neuromyelitis optica, in this report we focused on Glucocorticoids such as Methylprednisolone and Immunoglobulin such as IVIg.
This report includes market status and forecast of global and major regions, with introduction of vendors, regions, product types and end industries; and this report counts product types and end industries in global and major regions.
The report includes as follows:
The report provides current data, historical overview and future forecast.
The report includes an in-depth analysis of the Global market for Neuromyelitis Optica Drug , covering Global total and major region markets.
The data of 2017-2025 are included. All-inclusive market are given through data on sales, consumption, and prices (Global total and by major regions).
The report provides introduction of leading Global manufacturers.
Neuromyelitis Optica Drug market prospects to 2025 are included (in sales, consumption and price).
Market Segment as follows:
By Region / Countries
- North America (U.S., Canada, Mexico)
- Europe (Germany, U.K., France, Italy, Russia, Spain etc)
- Asia-Pacific (China, India, Japan, Southeast Asia etc)
- South America (Brazil, Argentina etc)
- Middle East & Africa (Saudi Arabia, South Africa etc)
- Production Market Share
- Price Rage
- Cost
- Acute attack
- Remission prophylactic treatment
- Pfizer
- FRESENIUS
- TEVA
- SANDOZ
- Intas
- Gyjtrs
- NANG KUANG
- Tianjin Kingyork
- Baxter
- CSL
- Grifols
- Octapharma
- CBOP
1 MARKET DEFINITION
1.1 Market Segment Overview
1.2 by Type
1.3 by End-Use / Application
2 GLOBAL MARKET BY VENDORS
2.1 Market Share
2.2 Vendor Profile
2.3 Dynamic of Vendors
3 GLOBAL MARKET BY TYPE
3.1 Market Share
3.2 Introduction of End-Use by Different Products
4 GLOBAL MARKET BY END-USE / APPLICATION
4.1 Market Share
4.2 Overview of Consumption Characteristics
4.2.1 Preference Driven
4.2.2 Substitutability
4.2.3 Influence by Strategy
4.2.4 Professional Needs
5 GLOBAL MARKET BY REGIONS
5.1 Market Share
5.2 Regional Market Growth
5.2.1 North America
5.2.2 Europe
5.2.3 Asia-Pacific
5.2.4 South America
5.2.5 Middle East & Africa
6 NORTH AMERICA MARKET
6.1 by Type
6.2 by End-Use / Application
6.3 by Regions
7 EUROPE MARKET
7.1 by Type
7.2 by End-Use / Application
7.3 by Regions
8 ASIA-PACIFIC MARKET
8.1 by Type
8.2 by End-Use / Application
8.3 by Regions
9 SOUTH AMERICA MARKET
9.1 by Type
9.2 by End-Use / Application
9.3 by Regions
10 MIDDLE EAST & AFRICA MARKET
10.1 by Type
10.2 by End-Use / Application
10.3 by Regions
11 MARKET FORECAST
11.1 Global Market Forecast (2020-2025)
11.2 Market Forecast by Regions (2020-2025)
11.3 Market Forecast by Type (2020-2025)
11.4 Market Forecast by End-Use / Application (2020-2025)
12 KEY MANUFACTURERS
12.CAPSTONE PFIZER
12.1.2 Company Overview
12.1.2 Product and End-User / Application
12.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.2 FRESENIUS
12.3 TEVA
12.4 SANDOZ
12.5 Intas
12.6 Gyjtrs
12.7 NANG KUANG
12.8 Tianjin Kingyork
12.9 Baxter
12.10 CSL
12.11 Grifols
12.12 Octapharma
12.13 CBOP
13 PRICE OVERVIEW
13.1 Price Segment
13.2 Price Trend
14 RESEARCH CONCLUSION
1.1 Market Segment Overview
1.2 by Type
1.3 by End-Use / Application
2 GLOBAL MARKET BY VENDORS
2.1 Market Share
2.2 Vendor Profile
2.3 Dynamic of Vendors
3 GLOBAL MARKET BY TYPE
3.1 Market Share
3.2 Introduction of End-Use by Different Products
4 GLOBAL MARKET BY END-USE / APPLICATION
4.1 Market Share
4.2 Overview of Consumption Characteristics
4.2.1 Preference Driven
4.2.2 Substitutability
4.2.3 Influence by Strategy
4.2.4 Professional Needs
5 GLOBAL MARKET BY REGIONS
5.1 Market Share
5.2 Regional Market Growth
5.2.1 North America
5.2.2 Europe
5.2.3 Asia-Pacific
5.2.4 South America
5.2.5 Middle East & Africa
6 NORTH AMERICA MARKET
6.1 by Type
6.2 by End-Use / Application
6.3 by Regions
7 EUROPE MARKET
7.1 by Type
7.2 by End-Use / Application
7.3 by Regions
8 ASIA-PACIFIC MARKET
8.1 by Type
8.2 by End-Use / Application
8.3 by Regions
9 SOUTH AMERICA MARKET
9.1 by Type
9.2 by End-Use / Application
9.3 by Regions
10 MIDDLE EAST & AFRICA MARKET
10.1 by Type
10.2 by End-Use / Application
10.3 by Regions
11 MARKET FORECAST
11.1 Global Market Forecast (2020-2025)
11.2 Market Forecast by Regions (2020-2025)
11.3 Market Forecast by Type (2020-2025)
11.4 Market Forecast by End-Use / Application (2020-2025)
12 KEY MANUFACTURERS
12.CAPSTONE PFIZER
12.1.2 Company Overview
12.1.2 Product and End-User / Application
12.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.2 FRESENIUS
12.3 TEVA
12.4 SANDOZ
12.5 Intas
12.6 Gyjtrs
12.7 NANG KUANG
12.8 Tianjin Kingyork
12.9 Baxter
12.10 CSL
12.11 Grifols
12.12 Octapharma
12.13 CBOP
13 PRICE OVERVIEW
13.1 Price Segment
13.2 Price Trend
14 RESEARCH CONCLUSION
LIST OF TABLES
Table Global Neuromyelitis Optica Drug Market and Growth by Type
Table Global Neuromyelitis Optica Drug Market and Growth by End-Use / Application
Table Global Neuromyelitis Optica Drug Revenue (Million USD) by Vendors (2017-2019)
Table Global Neuromyelitis Optica Drug Revenue Share by Vendors (2017-2019)
Table Global Neuromyelitis Optica Drug Market Volume (Volume) by Vendors (2017-2019)
Table Global Neuromyelitis Optica Drug Market Volume Share by Vendors (2017-2019)
Table Headquarter, Factories & Sales Regions Comparison of Vendors
Table Product List of Vendors
Table Global Neuromyelitis Optica Drug Market (Million USD) by Type (2017-2019)
Table Global Neuromyelitis Optica Drug Market Share by Type (2017-2019)
Table Global Neuromyelitis Optica Drug Market Volume (Volume) by Type (2017-2019)
Table Global Neuromyelitis Optica Drug Market Volume Share by Type (2017-2019)
Table Global Neuromyelitis Optica Drug Market (Million USD) by End-Use / Application (2017-2019)
Table Global Neuromyelitis Optica Drug Market Share by End-Use / Application (2017-2019)
Table Global Neuromyelitis Optica Drug Market Volume (Volume) by End-Use / Application (2017-2019)
Table Global Neuromyelitis Optica Drug Market Volume Share by End-Use / Application (2017-2019)
Table Global Neuromyelitis Optica Drug Market (Million USD) by Regions (2017-2019)
Table Global Neuromyelitis Optica Drug Market Share by Regions (2017-2019)
Table Global Neuromyelitis Optica Drug Market Volume (Volume) by Regions (2017-2019)
Table Global Neuromyelitis Optica Drug Market Volume Share by Regions (2017-2019)
Table North America Neuromyelitis Optica Drug Market (Million USD) by Type (2017-2019)
Table North America Neuromyelitis Optica Drug Market Share by Type (2017-2019)
Table North America Neuromyelitis Optica Drug Market (Million USD) by End-Use / Application (2017-2019)
Table North America Neuromyelitis Optica Drug Market Share by End-Use / Application (2017-2019)
Table North America Neuromyelitis Optica Drug Market (Million USD) by Regions (2017-2019)
Table North America Neuromyelitis Optica Drug Market Share by Regions (2017-2019)
Table Europe Neuromyelitis Optica Drug Market (Million USD) by Type (2017-2019)
Table Europe Neuromyelitis Optica Drug Market Share by Type (2017-2019)
Table Europe Neuromyelitis Optica Drug Market (Million USD) by End-Use / Application (2017-2019)
Table Europe Neuromyelitis Optica Drug Market Share by End-Use / Application (2017-2019)
Table Europe Neuromyelitis Optica Drug Market (Million USD) by Regions (2017-2019)
Table Europe Neuromyelitis Optica Drug Market Share by Regions (2017-2019)
Table Asia-Pacific Neuromyelitis Optica Drug Market (Million USD) by Type (2017-2019)
Table Asia-Pacific Neuromyelitis Optica Drug Market Share by Type (2017-2019)
Table Asia-Pacific Neuromyelitis Optica Drug Market (Million USD) by End-Use / Application (2017-2019)
Table Asia-Pacific Neuromyelitis Optica Drug Market Share by End-Use / Application (2017-2019)
Table Asia-Pacific Neuromyelitis Optica Drug Market (Million USD) by Regions (2017-2019)
Table Asia-Pacific Neuromyelitis Optica Drug Market Share by Regions (2017-2019)
Table South America Neuromyelitis Optica Drug Market (Million USD) by Type (2017-2019)
Table South America Neuromyelitis Optica Drug Market Share by Type (2017-2019)
Table South America Neuromyelitis Optica Drug Market (Million USD) by End-Use / Application (2017-2019)
Table South America Neuromyelitis Optica Drug Market Share by End-Use / Application (2017-2019)
Table South America Neuromyelitis Optica Drug Market (Million USD) by Regions (2017-2019)
Table Middle East & Africa Neuromyelitis Optica Drug Market Share by Regions (2017-2019)
Table Middle East & Africa Neuromyelitis Optica Drug Market (Million USD) by Type (2017-2019)
Table Middle East & Africa Neuromyelitis Optica Drug Market Share by Type (2017-2019)
Table Middle East & Africa Neuromyelitis Optica Drug Market (Million USD) by End-Use / Application (2017-2019)
Table Middle East & Africa Neuromyelitis Optica Drug Market Share by End-Use / Application (2017-2019)
Table Middle East & Africa Neuromyelitis Optica Drug Market (Million USD) by Regions (2017-2019)
Table Middle East & Africa Neuromyelitis Optica Drug Market Share by Regions (2017-2019)
Table Global Neuromyelitis Optica Drug Market (Million USD) Forecast by Regions (2020-2025)
Table Global Neuromyelitis Optica Drug Market Share Forecast by Regions (2020-2025)
Table Global Neuromyelitis Optica Drug Market Volume (Volume) Forecast by Regions (2020-2025)
Table Global Neuromyelitis Optica Drug Market Volume Share Forecast by Regions (2020-2025)
Table Global Neuromyelitis Optica Drug Market (Million USD) Forecast by Type (2020-2025)
Table Global Neuromyelitis Optica DrugMarket Share by Forecast Type (2020-2025)
Table Global Neuromyelitis Optica Drug Market (Million USD) Forecast by End-Use / Application (2020-2025)
Table Global Neuromyelitis Optica Drug Market Share Forecast by End-Use / Application (2020-2025)
Table Sales Revenue, Volume, Price, Cost and Margin of Pfizer
Table Sales Revenue, Volume, Price, Cost and Margin of FRESENIUS
Table Sales Revenue, Volume, Price, Cost and Margin of TEVA
Table Sales Revenue, Volume, Price, Cost and Margin of SANDOZ
Table Sales Revenue, Volume, Price, Cost and Margin of Intas
Table Sales Revenue, Volume, Price, Cost and Margin of Gyjtrs
Table Sales Revenue, Volume, Price, Cost and Margin of NANG KUANG
Table Sales Revenue, Volume, Price, Cost and Margin of Tianjin Kingyork
Table Sales Revenue, Volume, Price, Cost and Margin of Baxter
Table Sales Revenue, Volume, Price, Cost and Margin of CSL
Table Sales Revenue, Volume, Price, Cost and Margin of Grifols
Table Sales Revenue, Volume, Price, Cost and Margin of Octapharma
Table Sales Revenue, Volume, Price, Cost and Margin of CBOP
Table Global Neuromyelitis Optica Drug Market and Growth by Type
Table Global Neuromyelitis Optica Drug Market and Growth by End-Use / Application
Table Global Neuromyelitis Optica Drug Revenue (Million USD) by Vendors (2017-2019)
Table Global Neuromyelitis Optica Drug Revenue Share by Vendors (2017-2019)
Table Global Neuromyelitis Optica Drug Market Volume (Volume) by Vendors (2017-2019)
Table Global Neuromyelitis Optica Drug Market Volume Share by Vendors (2017-2019)
Table Headquarter, Factories & Sales Regions Comparison of Vendors
Table Product List of Vendors
Table Global Neuromyelitis Optica Drug Market (Million USD) by Type (2017-2019)
Table Global Neuromyelitis Optica Drug Market Share by Type (2017-2019)
Table Global Neuromyelitis Optica Drug Market Volume (Volume) by Type (2017-2019)
Table Global Neuromyelitis Optica Drug Market Volume Share by Type (2017-2019)
Table Global Neuromyelitis Optica Drug Market (Million USD) by End-Use / Application (2017-2019)
Table Global Neuromyelitis Optica Drug Market Share by End-Use / Application (2017-2019)
Table Global Neuromyelitis Optica Drug Market Volume (Volume) by End-Use / Application (2017-2019)
Table Global Neuromyelitis Optica Drug Market Volume Share by End-Use / Application (2017-2019)
Table Global Neuromyelitis Optica Drug Market (Million USD) by Regions (2017-2019)
Table Global Neuromyelitis Optica Drug Market Share by Regions (2017-2019)
Table Global Neuromyelitis Optica Drug Market Volume (Volume) by Regions (2017-2019)
Table Global Neuromyelitis Optica Drug Market Volume Share by Regions (2017-2019)
Table North America Neuromyelitis Optica Drug Market (Million USD) by Type (2017-2019)
Table North America Neuromyelitis Optica Drug Market Share by Type (2017-2019)
Table North America Neuromyelitis Optica Drug Market (Million USD) by End-Use / Application (2017-2019)
Table North America Neuromyelitis Optica Drug Market Share by End-Use / Application (2017-2019)
Table North America Neuromyelitis Optica Drug Market (Million USD) by Regions (2017-2019)
Table North America Neuromyelitis Optica Drug Market Share by Regions (2017-2019)
Table Europe Neuromyelitis Optica Drug Market (Million USD) by Type (2017-2019)
Table Europe Neuromyelitis Optica Drug Market Share by Type (2017-2019)
Table Europe Neuromyelitis Optica Drug Market (Million USD) by End-Use / Application (2017-2019)
Table Europe Neuromyelitis Optica Drug Market Share by End-Use / Application (2017-2019)
Table Europe Neuromyelitis Optica Drug Market (Million USD) by Regions (2017-2019)
Table Europe Neuromyelitis Optica Drug Market Share by Regions (2017-2019)
Table Asia-Pacific Neuromyelitis Optica Drug Market (Million USD) by Type (2017-2019)
Table Asia-Pacific Neuromyelitis Optica Drug Market Share by Type (2017-2019)
Table Asia-Pacific Neuromyelitis Optica Drug Market (Million USD) by End-Use / Application (2017-2019)
Table Asia-Pacific Neuromyelitis Optica Drug Market Share by End-Use / Application (2017-2019)
Table Asia-Pacific Neuromyelitis Optica Drug Market (Million USD) by Regions (2017-2019)
Table Asia-Pacific Neuromyelitis Optica Drug Market Share by Regions (2017-2019)
Table South America Neuromyelitis Optica Drug Market (Million USD) by Type (2017-2019)
Table South America Neuromyelitis Optica Drug Market Share by Type (2017-2019)
Table South America Neuromyelitis Optica Drug Market (Million USD) by End-Use / Application (2017-2019)
Table South America Neuromyelitis Optica Drug Market Share by End-Use / Application (2017-2019)
Table South America Neuromyelitis Optica Drug Market (Million USD) by Regions (2017-2019)
Table Middle East & Africa Neuromyelitis Optica Drug Market Share by Regions (2017-2019)
Table Middle East & Africa Neuromyelitis Optica Drug Market (Million USD) by Type (2017-2019)
Table Middle East & Africa Neuromyelitis Optica Drug Market Share by Type (2017-2019)
Table Middle East & Africa Neuromyelitis Optica Drug Market (Million USD) by End-Use / Application (2017-2019)
Table Middle East & Africa Neuromyelitis Optica Drug Market Share by End-Use / Application (2017-2019)
Table Middle East & Africa Neuromyelitis Optica Drug Market (Million USD) by Regions (2017-2019)
Table Middle East & Africa Neuromyelitis Optica Drug Market Share by Regions (2017-2019)
Table Global Neuromyelitis Optica Drug Market (Million USD) Forecast by Regions (2020-2025)
Table Global Neuromyelitis Optica Drug Market Share Forecast by Regions (2020-2025)
Table Global Neuromyelitis Optica Drug Market Volume (Volume) Forecast by Regions (2020-2025)
Table Global Neuromyelitis Optica Drug Market Volume Share Forecast by Regions (2020-2025)
Table Global Neuromyelitis Optica Drug Market (Million USD) Forecast by Type (2020-2025)
Table Global Neuromyelitis Optica DrugMarket Share by Forecast Type (2020-2025)
Table Global Neuromyelitis Optica Drug Market (Million USD) Forecast by End-Use / Application (2020-2025)
Table Global Neuromyelitis Optica Drug Market Share Forecast by End-Use / Application (2020-2025)
Table Sales Revenue, Volume, Price, Cost and Margin of Pfizer
Table Sales Revenue, Volume, Price, Cost and Margin of FRESENIUS
Table Sales Revenue, Volume, Price, Cost and Margin of TEVA
Table Sales Revenue, Volume, Price, Cost and Margin of SANDOZ
Table Sales Revenue, Volume, Price, Cost and Margin of Intas
Table Sales Revenue, Volume, Price, Cost and Margin of Gyjtrs
Table Sales Revenue, Volume, Price, Cost and Margin of NANG KUANG
Table Sales Revenue, Volume, Price, Cost and Margin of Tianjin Kingyork
Table Sales Revenue, Volume, Price, Cost and Margin of Baxter
Table Sales Revenue, Volume, Price, Cost and Margin of CSL
Table Sales Revenue, Volume, Price, Cost and Margin of Grifols
Table Sales Revenue, Volume, Price, Cost and Margin of Octapharma
Table Sales Revenue, Volume, Price, Cost and Margin of CBOP
LIST OF FIGURES
Figure Global Neuromyelitis Optica Drug Market Size (Million USD) 2017-2025
Figure North America Market Growth 2015-2018
Figure Europe Market Growth 2017-2019
Figure Asia-Pacific Market Growth 2017-2019
Figure South America Market Growth 2017-2019
Figure Middle East & Africa Market Growth 2017-2019
Figure Global Neuromyelitis Optica Drug Market (Million USD) and Growth Forecast (2020-2025)
Figure Global Neuromyelitis Optica Drug Market Volume (Volume) and Growth Forecast (2020-2025)
Figure Global Neuromyelitis Optica Drug Market Size (Million USD) 2017-2025
Figure North America Market Growth 2015-2018
Figure Europe Market Growth 2017-2019
Figure Asia-Pacific Market Growth 2017-2019
Figure South America Market Growth 2017-2019
Figure Middle East & Africa Market Growth 2017-2019
Figure Global Neuromyelitis Optica Drug Market (Million USD) and Growth Forecast (2020-2025)
Figure Global Neuromyelitis Optica Drug Market Volume (Volume) and Growth Forecast (2020-2025)
